Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study

the ConquerFear Authorship Group

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose: Despite the prevalence of fear of cancer recurrence (FCR), understanding of factors underlying clinically significant FCR is limited. This study examined factors associated with greater FCR morbidity, according to a cognitive processing model, in cancer survivors who screened positively for clinically significant FCR seeking psychological treatment through the ConquerFear trial. Methods: Participants had completed treatment for breast, colorectal or melanoma cancer 2 months to 5 years previously and scored ≥ 13/36 on the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF). Hierarchical regression analyses examined associations between demographic, medical and psychological variables, namely metacognitions (MCQ-30), post-traumatic stress symptoms (IES-R) and FCR (FCRI total score). Results: Two hundred and ten (95%) of the 222 cancer survivors who consented to the ConquerFear trial completed the baseline questionnaire. Participants were predominantly (89%) breast cancer survivors. The final regression model accounted for 68% of the variance in FCR (demographic and medical variables 13%, metacognitions 26%, post-traumatic stress symptoms 28%). Negative metacognitive beliefs about worry and intrusive post-traumatic stress symptoms were significant individual correlates of FCR, but negative beliefs about worry did not significantly moderate the impact of intrusions on FCR morbidity. Conclusions: Results provide partial support for the cognitive processing model of FCR. Psychological factors were found to play an important role in FCR morbidity after controlling for demographic/medical factors. More intrusive thoughts and negative beliefs about worry were strong independent predictors of FCR morbidity. Cancer survivors with clinically significant FCR may benefit from assessment for intrusive thoughts and metacognitions and delivery of trauma- and/or metacognitive-based interventions accordingly.

Original languageEnglish (US)
Pages (from-to)4207-4216
Number of pages10
JournalSupportive Care in Cancer
Volume26
Issue number12
DOIs
StatePublished - Dec 1 2018

Fingerprint

Fear
Survivors
Colorectal Neoplasms
Melanoma
Breast
Demography
Psychology
Morbidity
Recurrence
Neoplasms
Therapeutics

Keywords

  • Cancer
  • Fear of cancer recurrence
  • Metacognitions
  • Post-traumatic stress
  • Supportive care
  • Survivorship

ASJC Scopus subject areas

  • Oncology

Cite this

@article{e41f6ac42be94134b34618b3b0461964,
title = "Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study",
abstract = "Purpose: Despite the prevalence of fear of cancer recurrence (FCR), understanding of factors underlying clinically significant FCR is limited. This study examined factors associated with greater FCR morbidity, according to a cognitive processing model, in cancer survivors who screened positively for clinically significant FCR seeking psychological treatment through the ConquerFear trial. Methods: Participants had completed treatment for breast, colorectal or melanoma cancer 2 months to 5 years previously and scored ≥ 13/36 on the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF). Hierarchical regression analyses examined associations between demographic, medical and psychological variables, namely metacognitions (MCQ-30), post-traumatic stress symptoms (IES-R) and FCR (FCRI total score). Results: Two hundred and ten (95{\%}) of the 222 cancer survivors who consented to the ConquerFear trial completed the baseline questionnaire. Participants were predominantly (89{\%}) breast cancer survivors. The final regression model accounted for 68{\%} of the variance in FCR (demographic and medical variables 13{\%}, metacognitions 26{\%}, post-traumatic stress symptoms 28{\%}). Negative metacognitive beliefs about worry and intrusive post-traumatic stress symptoms were significant individual correlates of FCR, but negative beliefs about worry did not significantly moderate the impact of intrusions on FCR morbidity. Conclusions: Results provide partial support for the cognitive processing model of FCR. Psychological factors were found to play an important role in FCR morbidity after controlling for demographic/medical factors. More intrusive thoughts and negative beliefs about worry were strong independent predictors of FCR morbidity. Cancer survivors with clinically significant FCR may benefit from assessment for intrusive thoughts and metacognitions and delivery of trauma- and/or metacognitive-based interventions accordingly.",
keywords = "Cancer, Fear of cancer recurrence, Metacognitions, Post-traumatic stress, Supportive care, Survivorship",
author = "{the ConquerFear Authorship Group} and Smith, {Allan ‘Ben’} and Louise Sharpe and Belinda Thewes and Jane Turner and Jemma Gilchrist and Fardell, {Joanna E.} and Afaf Girgis and Stephanie Tesson and Joseph Descallar and Bell, {Melanie L} and Jane Beith and Phyllis Butow and Lisa Beatty and Barbara Bennett and Rachel Brebach and Christina Brock and Sue Butler and Donna Byrne and Sinead Day and Justine Diggens and Amanda Fairclough and Therese Faulkner and Maria Ftanou and Maree Grier and Geraldine Hill and Tessa Jones and Laura Kirsten and Sue McConaghey and Sarah McKinnon and Catherine Mihalopoulos and Shab Mireskandari and Toni Musiello and James Penhale and Annabel Pollard and Anita Rangganadhan and Marita Scealy and Mary Scott and Sophy Shih and Mey Teoh and Kerry Tiller and Paula Watt",
year = "2018",
month = "12",
day = "1",
doi = "10.1007/s00520-018-4294-y",
language = "English (US)",
volume = "26",
pages = "4207--4216",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study

AU - the ConquerFear Authorship Group

AU - Smith, Allan ‘Ben’

AU - Sharpe, Louise

AU - Thewes, Belinda

AU - Turner, Jane

AU - Gilchrist, Jemma

AU - Fardell, Joanna E.

AU - Girgis, Afaf

AU - Tesson, Stephanie

AU - Descallar, Joseph

AU - Bell, Melanie L

AU - Beith, Jane

AU - Butow, Phyllis

AU - Beatty, Lisa

AU - Bennett, Barbara

AU - Brebach, Rachel

AU - Brock, Christina

AU - Butler, Sue

AU - Byrne, Donna

AU - Day, Sinead

AU - Diggens, Justine

AU - Fairclough, Amanda

AU - Faulkner, Therese

AU - Ftanou, Maria

AU - Grier, Maree

AU - Hill, Geraldine

AU - Jones, Tessa

AU - Kirsten, Laura

AU - McConaghey, Sue

AU - McKinnon, Sarah

AU - Mihalopoulos, Catherine

AU - Mireskandari, Shab

AU - Musiello, Toni

AU - Penhale, James

AU - Pollard, Annabel

AU - Rangganadhan, Anita

AU - Scealy, Marita

AU - Scott, Mary

AU - Shih, Sophy

AU - Teoh, Mey

AU - Tiller, Kerry

AU - Watt, Paula

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Purpose: Despite the prevalence of fear of cancer recurrence (FCR), understanding of factors underlying clinically significant FCR is limited. This study examined factors associated with greater FCR morbidity, according to a cognitive processing model, in cancer survivors who screened positively for clinically significant FCR seeking psychological treatment through the ConquerFear trial. Methods: Participants had completed treatment for breast, colorectal or melanoma cancer 2 months to 5 years previously and scored ≥ 13/36 on the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF). Hierarchical regression analyses examined associations between demographic, medical and psychological variables, namely metacognitions (MCQ-30), post-traumatic stress symptoms (IES-R) and FCR (FCRI total score). Results: Two hundred and ten (95%) of the 222 cancer survivors who consented to the ConquerFear trial completed the baseline questionnaire. Participants were predominantly (89%) breast cancer survivors. The final regression model accounted for 68% of the variance in FCR (demographic and medical variables 13%, metacognitions 26%, post-traumatic stress symptoms 28%). Negative metacognitive beliefs about worry and intrusive post-traumatic stress symptoms were significant individual correlates of FCR, but negative beliefs about worry did not significantly moderate the impact of intrusions on FCR morbidity. Conclusions: Results provide partial support for the cognitive processing model of FCR. Psychological factors were found to play an important role in FCR morbidity after controlling for demographic/medical factors. More intrusive thoughts and negative beliefs about worry were strong independent predictors of FCR morbidity. Cancer survivors with clinically significant FCR may benefit from assessment for intrusive thoughts and metacognitions and delivery of trauma- and/or metacognitive-based interventions accordingly.

AB - Purpose: Despite the prevalence of fear of cancer recurrence (FCR), understanding of factors underlying clinically significant FCR is limited. This study examined factors associated with greater FCR morbidity, according to a cognitive processing model, in cancer survivors who screened positively for clinically significant FCR seeking psychological treatment through the ConquerFear trial. Methods: Participants had completed treatment for breast, colorectal or melanoma cancer 2 months to 5 years previously and scored ≥ 13/36 on the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF). Hierarchical regression analyses examined associations between demographic, medical and psychological variables, namely metacognitions (MCQ-30), post-traumatic stress symptoms (IES-R) and FCR (FCRI total score). Results: Two hundred and ten (95%) of the 222 cancer survivors who consented to the ConquerFear trial completed the baseline questionnaire. Participants were predominantly (89%) breast cancer survivors. The final regression model accounted for 68% of the variance in FCR (demographic and medical variables 13%, metacognitions 26%, post-traumatic stress symptoms 28%). Negative metacognitive beliefs about worry and intrusive post-traumatic stress symptoms were significant individual correlates of FCR, but negative beliefs about worry did not significantly moderate the impact of intrusions on FCR morbidity. Conclusions: Results provide partial support for the cognitive processing model of FCR. Psychological factors were found to play an important role in FCR morbidity after controlling for demographic/medical factors. More intrusive thoughts and negative beliefs about worry were strong independent predictors of FCR morbidity. Cancer survivors with clinically significant FCR may benefit from assessment for intrusive thoughts and metacognitions and delivery of trauma- and/or metacognitive-based interventions accordingly.

KW - Cancer

KW - Fear of cancer recurrence

KW - Metacognitions

KW - Post-traumatic stress

KW - Supportive care

KW - Survivorship

UR - http://www.scopus.com/inward/record.url?scp=85048140276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048140276&partnerID=8YFLogxK

U2 - 10.1007/s00520-018-4294-y

DO - 10.1007/s00520-018-4294-y

M3 - Article

VL - 26

SP - 4207

EP - 4216

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 12

ER -